Loading...
Header Logo
Keywords
Last Name
Institution

Dr Angelique Luabeya Kany Kany

TitleSenior research officer
InstitutionUniversity of Cape Town
DepartmentPathgology
AddressCape Town
South Africa
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z, Tait D, Kromann I, Ruhwald M, Rutkowski KT, Shepherd B, Hokey D, Ginsberg AM, Hanekom WA, Andersen P, Scriba TJ, Hatherill M. Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial. Am J Respir Crit Care Med. 2019 Jan 15; 199(2):220-231. PMID: 30092143.
      View in: PubMed
    2. Penn-Nicholson A, Tameris M, Smit E, Day TA, Musvosvi M, Jayashankar L, Vergara J, Mabwe S, Bilek N, Geldenhuys H, Luabeya AK, Ellis R, Ginsberg AM, Hanekom WA, Reed SG, Coler RN, Scriba TJ, Hatherill M. Safety and immunogenicity of the novel tuberculosis vaccine ID93?+?GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. Lancet Respir Med. 2018 04; 6(4):287-298. PMID: 29595510.
      View in: PubMed
    3. Nemes E, Hesseling AC, Tameris M, Mauff K, Downing K, Mulenga H, Rose P, van der Zalm M, Mbaba S, Van As D, Hanekom WA, Walzl G, Scriba TJ, McShane H, Hatherill M. Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin for Infants of Human Immunodeficiency Virus-Infected Mothers: A Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2018 02 01; 66(4):554-563. PMID: 29028973.
      View in: PubMed
    4. Schmidt BM, Tameris M, Geldenhuys H, Luabeya A, Bunyasi E, Hawkridge T, McClain JB, Mahomed H, Scriba TJ, McShane H, Hatherill M. Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals. Trop Med Int Health. 2018 01; 23(1):63-68. PMID: 29140587.
      View in: PubMed
    5. Schmidt BM, Geldenhuys H, Tameris M, Luabeya A, Mulenga H, Bunyasi E, Scriba T, Hatherill M. Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community. S Afr Med J. 2017 Nov 27; 107(12):1078-1081. PMID: 29262960.
      View in: PubMed
    6. Bunyasi EW, Luabeya AKK, Tameris M, Geldenhuys H, Mulenga H, Landry BS, Scriba TJ, Schmidt BM, Hanekom WA, Mahomed H, McShane H, Hatherill M. Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination. Int J Tuberc Lung Dis. 2017 07 01; 21(7):778-783. PMID: 28633702.
      View in: PubMed
    7. Bunyasi EW, Schmidt BM, Abdullahi LH, Mulenga H, Tameris M, Luabeya A, Shenje J, Scriba T, Geldenhuys H, Wood R, Hatherill M. Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol. BMJ Open. 2017 03 10; 7(3):e014609. PMID: 28283492.
      View in: PubMed
    8. Bunyasi EW, Tameris M, Geldenhuys H, Schmidt BM, Luabeya AK, Mulenga H, Scriba TJ, Hanekom WA, Mahomed H, McShane H, Hatherill M. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial. PLoS One. 2015; 10(11):e0141623. PMID: 26554383.
      View in: PubMed
    9. Mulenga H, Tameris MD, Luabeya KK, Geldenhuys H, Scriba TJ, Hussey GD, Mahomed H, Landry BS, Hanekom WA, McShane H, Hatherill M. The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children. Pediatr Infect Dis J. 2015 Nov; 34(11):1157-62. PMID: 26226446.
      View in: PubMed
    10. Luabeya KK, Tameris MD, Geldenhuys HD, Mulenga H, Van Schalkwyk A, Hughes EJ, Toefey A, Scriba TJ, Hussey G, Mahomed H, McShane H, Landry B, Hanekom WA, Hatherill M. Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children. Pediatr Infect Dis J. 2015 Nov; 34(11):1218-22. PMID: 26252568.
      View in: PubMed
    11. Luabeya AK, Kagina BM, Tameris MD, Geldenhuys H, Hoff ST, Shi Z, Kromann I, Hatherill M, Mahomed H, Hanekom WA, Andersen P, Scriba TJ. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Vaccine. 2015 Aug 07; 33(33):4130-40. PMID: 26095509.
      View in: PubMed
    12. Penn-Nicholson A, Geldenhuys H, Burny W, van der Most R, Day CL, Jongert E, Moris P, Hatherill M, Ofori-Anyinam O, Hanekom W. Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting. Vaccine. 2015 Jul 31; 33(32):4025-34. PMID: 26072017.
      View in: PubMed
    13. Tameris M, Hokey DA, Nduba V, Sacarlal J, Laher F, Kiringa G, Gondo K, Lazarus EM, Gray GE, Nachman S, Mahomed H, Downing K, Abel B, Scriba TJ, McClain JB, Pau MG, Hendriks J, Dheenadhayalan V, Ishmukhamedov S, Luabeya AK, Geldenhuys H, Shepherd B, Blatner G, Cardenas V, Walker R, Hanekom WA, Sadoff J, Douoguih M, Barker L, Hatherill M. A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Vaccine. 2015 Jun 09; 33(25):2944-54. PMID: 25936724.
      View in: PubMed
    14. Geldenhuys HD, Mearns H, Foster J, Saxon E, Kagina B, Saganic L, Jarrahian C, Tameris MD, Dintwe OB, Van Rooyen M, Luabeya KK, Hussey G, Scriba TJ, Hatherill M, Zehrung D. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe. Vaccine. 2015 Sep 08; 33(37):4719-26. PMID: 25862299.
      View in: PubMed
    15. Wood RC, Luabeya AK, Weigel KM, Wilbur AK, Jones-Engel L, Hatherill M, Cangelosi GA. Detection of Mycobacterium tuberculosis DNA on the oral mucosa of tuberculosis patients. Sci Rep. 2015 Mar 02; 5:8668. PMID: 25727773.
      View in: PubMed
    16. Mpofu N, Moyo S, Mulenga H, Luabeya KK, Tameris M, Geldenhuys H, Hussey G, Scriba T, Hanekom W, Mahomed H, Hatherill M. Time to symptom resolution in young children treated for pulmonary tuberculosis. Pediatr Infect Dis J. 2014 Dec; 33(12):1226-30. PMID: 25144794.
      View in: PubMed
    17. Geldenhuys HD, Whitelaw A, Tameris MD, Van As D, Luabeya KK, Mahomed H, Hussey G, Hanekom WA, Hatherill M. A controlled trial of sputum induction and routine collection methods for TB diagnosis in a South African community. Eur J Clin Microbiol Infect Dis. 2014 Dec; 33(12):2259-66. PMID: 25022447.
      View in: PubMed
    18. Tameris M, Geldenhuys H, Luabeya AK, Smit E, Hughes JE, Vermaak S, Hanekom WA, Hatherill M, Mahomed H, McShane H, Scriba TJ. The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. PLoS One. 2014; 9(2):e87340. PMID: 24498312.
      View in: PubMed
    19. Chhagan MK, Van den Broeck J, Luabeya KK, Mpontshane N, Bennish ML. Cost of childhood diarrhoea in rural South Africa: exploring cost-effectiveness of universal zinc supplementation. Public Health Nutr. 2014 Sep; 17(9):2138-45. PMID: 23930984.
      View in: PubMed
    20. Tameris M, McShane H, McClain JB, Landry B, Lockhart S, Luabeya AK, Geldenhuys H, Shea J, Hussey G, van der Merwe L, de Kock M, Scriba T, Walker R, Hanekom W, Hatherill M, Mahomed H. Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. Tuberculosis (Edinb). 2013 Mar; 93(2):143-9. PMID: 23410889.
      View in: PubMed
    21. Geldenhuys H, Veldsman A, Tameris M, Luabeya A, Hanekom W, Mahomed H, Hatherill M. Analysis of time to regulatory and ethical approval of SATVI TB vaccine trials in South Africa. S Afr Med J. 2012 Nov 08; 103(2):85-9. PMID: 23374302.
      View in: PubMed
    22. Luabeya KK, Mulenga H, Moyo S, Tameris M, Sikhondze W, Geldenhuys H, Mohamed H, Hanekom W, Hussey G, Hatherill M. Diagnostic features associated with culture of Mycobacterium tuberculosis among young children in a vaccine trial setting. Pediatr Infect Dis J. 2012 Jan; 31(1):42-6. PMID: 22094639.
      View in: PubMed
    23. Chhagan MK, Van den Broeck J, Luabeya KK, Mpontshane N, Tomkins A, Bennish ML. Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months. BMC Public Health. 2010 Mar 18; 10:145. PMID: 20298571.
      View in: PubMed
    24. Chhagan MK, Van den Broeck J, Luabeya KK, Mpontshane N, Tucker KL, Bennish ML. Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa. Eur J Clin Nutr. 2009 Jul; 63(7):850-7. PMID: 19174830.
      View in: PubMed
    25. Luabeya KK, Mpontshane N, Mackay M, Ward H, Elson I, Chhagan M, Tomkins A, Van den Broeck J, Bennish ML. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS One. 2007 Jun 27; 2(6):e541. PMID: 17593956.
      View in: PubMed
    26. Van den Broeck J, Mackay M, Mpontshane N, Kany Kany Luabeya A, Chhagan M, Bennish ML. Maintaining data integrity in a rural clinical trial. Clin Trials. 2007; 4(5):572-82. PMID: 17942472.
      View in: PubMed
    Kany Kany's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _